Navidea’s Lymphoseek® Recommended by CHMP for E
Post# of 47
Posted On: 09/26/2014 9:07:35 AM
Navidea’s Lymphoseek® Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast and Certain Head and Neck CancersBusiness Wire(Fri 7:27AM EDT)
7:27 am Navidea Biopharma's Lymphoseek recommended by CHMP for European approval in sentinel lymph node detection for melanoma, breast and certain head and neck cancersBriefing.com(Fri 7:27AM EDT)
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, Sep 24)
Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of Lymphoseek® in Cervical CancerBusiness Wire(Tue, Sep 23)
Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck CancersBusiness Wire(Thu, Sep 18)
7:27 am Navidea Biopharma's Lymphoseek recommended by CHMP for European approval in sentinel lymph node detection for melanoma, breast and certain head and neck cancersBriefing.com(Fri 7:27AM EDT)
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, Sep 24)
Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of Lymphoseek® in Cervical CancerBusiness Wire(Tue, Sep 23)
Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck CancersBusiness Wire(Thu, Sep 18)
(0)
(0)Navidea Biopharmaceuticals Inc. (NAVB) Stock Research Links
Scroll down for more posts ▼